Xencor (XNCR) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

XNCR is expected to report earnings to fall 9.16% to -97 cents per share on November 05

Q3'24

Est.

$-0.97

Q2'24

Missed

by $0.25

Q1'24

Missed

by $0.30

Q4'23

Missed

by $0.20

Q3'23

Beat

by $0.33

The last earnings report on August 05 showed earnings per share of -107 cents, missing the estimate of -81 cents. With 433.41K shares outstanding, the current market capitalization sits at 1.42B.

View a ticker or compare two or three

Compare

XNCR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For XNCR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for XNCR (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutics to treat autoimmune and allergic diseases, cancer and other conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

465 North Halstead Street

Phone

+1 626 305-5900

Employees

256

Web

https://www.xencor.com